Literature DB >> 19341964

Accessing unfunded cancer drugs in publicly funded hospitals.

Roger Chafe1, Irfan A Dhalla, Mark Dobrow, Terrence Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19341964     DOI： 10.1016/S1470-2045(09)70039-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Variation and consternation: access to unfunded cancer drugs in Canada.

Authors:  Scott R Berry; William K Evans; Elizabeth L Strevel; Chaim M Bell
Journal:  J Oncol Pract       Date:  2012-01       Impact factor: 3.840

2.  International variability in the reimbursement of cancer drugs by publically funded drug programs.

Authors:  P K Cheema; S Gavura; M Migus; B Godman; L Yeung; M E Trudeau
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

3.  Tough choices: private sale of drugs in public hospitals.

Authors:  Colleen M Flood; Lorian Hardcastle
Journal:  CMAJ       Date:  2010-02-08       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.